DiscoverNucleate PodcastEngineering Dendritic Cells to Treat Cancer (Part 1) | Guardian Bio
Engineering Dendritic Cells to Treat Cancer (Part 1) |  Guardian Bio

Engineering Dendritic Cells to Treat Cancer (Part 1) | Guardian Bio

Update: 2024-08-12
Share

Description

In this episode of the Nucleate Podcast, we are joined by Ananya Zutshi and Ricky Barrett, founders of Guardian Bio, a Boston-based biotech company (and Nucleate Alumni). Their platform focuses on engineering dendritic cells to target solid tumors. We delve into the ups and downs of their entrepreneurial journey, the unique dynamic between co-founders, and their advice for communicating complex science topics.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Engineering Dendritic Cells to Treat Cancer (Part 1) |  Guardian Bio

Engineering Dendritic Cells to Treat Cancer (Part 1) | Guardian Bio

Ananya Zutshi, Ricky Barrett, Sam Kessel